コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 es additional epicardial ablation within the coronary sinus.
2 sion and MR was placed percutaneously in the coronary sinus.
3 ng a novel annuloplasty device placed in the coronary sinus.
4 nd proximal (p = 0.02) and distal (p < 0.01) coronary sinus.
5 teral right atrium, His bundle position, and coronary sinus.
6 sively moved from the distal to the proximal coronary sinus.
7 circumflex (CFX) arteries (CBF(LAD+CFX)) and coronary sinus.
8 complex lead systems including coils in the coronary sinus.
9 His bundle, posterior triangle of Koch, and coronary sinus.
10 the left atrial electrograms recorded in the coronary sinus.
11 dage, at the fossa ovalis, and in the distal coronary sinus.
12 ar diameter, with catheters in the aorta and coronary sinus.
13 od and blood continuously withdrawn from the coronary sinus.
14 om the high right atrium and from the distal coronary sinus.
15 ced into right atrium, pulmonary artery, and coronary sinus.
16 need for epicardial ablation from within the coronary sinus.
17 IIb/IIIa receptor occupancy measured in the coronary sinus.
18 s were taken from the femoral artery and the coronary sinus.
19 (161+/-22 vs 167+/-26 ms, P=0.05) and distal coronary sinus (162+/-20 vs 168+/-22 ms, P=0.01) sites.
20 roduced dose-related increases in aortic and coronary sinus 6-keto-prostaglandin F1 alpha and the tra
24 e right atrial septum and proximal-to-distal coronary sinus activation, 2) craniocaudal activation of
25 perimitral ATs, 13 focal ATs with sequential coronary sinus activation, and 13 other macroreentrant l
26 subeustachian isthmus and proximal-to-distal coronary sinus activation, and 3) caudocranial right atr
27 sed catheter ablation in the left atrium and coronary sinus after pulmonary vein isolation, were enro
28 the region extending from the AVN toward the coronary sinus along the tricuspid valve (posterior noda
29 n of electrograms recorded on the multipolar coronary sinus and ablation catheters was undertaken to
31 or function and intimal thickness as well as coronary sinus and aortic cytokine concentrations (tumor
32 locker," thus precluding "steal" through the coronary sinus and forcing retroperfusion of the anterio
34 nsmitral conduction block using differential coronary sinus and left atrial appendage pacing techniqu
35 ral isthmus linear lesion using differential coronary sinus and left atrial appendage pacing techniqu
37 een transvenous catheters, one in the distal coronary sinus and one in the right atrial appendage.
38 in seven swine; serial blood sampling of the coronary sinus and peripheral vein before, during, and a
39 dynamic responses, epinephrine levels in the coronary sinus and systemic circulation, and drug deposi
41 l block was identified between the os of the coronary sinus and the low lateral right atrium for both
46 undle position, a multipolar catheter in the coronary sinus, and a deflectable quadripolar catheter a
47 s were implanted into the right atrium (RA), coronary sinus, and left pulmonary artery of 14 dogs.
48 le, complex electrograms in the left atrium, coronary sinus, and superior vena cava were targeted for
50 th paroxysmal AF underwent balloon-occlusion coronary sinus angiograms to identify the vein of Marsha
53 utilization of substrates was calculated as coronary sinus-arterial difference times coronary flow.
55 were to evaluate the efficacy and safety of coronary sinus aspiration (CSA) procedure to reduce the
56 ial pacing in sinus rhythm from the proximal coronary sinus at a cycle length of 600 ms, until isthmu
59 FCL at the right atrial appendage and distal coronary sinus before attempting internal cardioversion
60 ary artery was rapid, reaching levels in the coronary sinus blood 4 to 10 times greater than that fou
61 ount to achieve a high drug concentration in coronary sinus blood causes a deterioration of LV systol
62 tes in serial paired peripheral arterial and coronary sinus blood effluents obtained from 37 patients
63 ary sinus blood sampling and measurements of coronary sinus blood flow were made during rest and atri
65 14)C-glucose were coinfused and arterial and coronary sinus blood sampled to measure cardiac free fat
68 ter FDG injection, paired basal arterial and coronary sinus blood samples were taken for the measurem
69 cts also underwent simultaneous arterial and coronary sinus blood sampling (to derive transcardiac co
74 e ascorbate free radical (AFR) signal in the coronary sinus blood; AFR is a measure of total oxidativ
75 heterogeneous within Koch's triangle and the coronary sinus, both for the entire population and for i
85 increased to 100 ng/min, corresponding to a coronary sinus concentration of 175 +/- 45 pg/mL (P < .0
86 ron paramagnetic resonance, we monitored the coronary sinus concentration of ascorbate free radical (
88 m connection was seen; however, all showed a coronary sinus constriction during atrial systole, indic
93 zed that both the patterns and the timing of coronary sinus (CS) activation could facilitate AT mappi
94 lasma samples were obtained from aorta (AO), coronary sinus (CS) and anterior interventricular vein (
95 vein (PV) ostium and simultaneously from the coronary sinus (CS) and posterior right atrium (RA) duri
96 s to describe the prevalence and ablation of coronary sinus (CS) arrhythmias after left atrial ablati
97 elationships between mitral annulus (MA) and coronary sinus (CS) as well as CS and left circumflex co
99 lock of tissue encompassing the LOM from the coronary sinus (CS) cephalad, between the atrial appenda
102 e of this study was to determine whether the coronary sinus (CS) musculature has electrical connectio
105 line of conduction block between the IVC and coronary sinus (CS) ostium and forms a second isthmus (s
106 he left atrium is activated, as reflected by coronary sinus (CS) recordings, has not been systematica
108 the pacing lead is usually positioned in the coronary sinus (CS) to stimulate the left ventricular (L
109 ation in humans, the release of vWF into the coronary sinus (CS) was measured in 32 patients during o
110 nfiguration, right atrial appendage (RAA) to coronary sinus (CS), was reduced by >50% with the additi
117 ther in the superior vena cava (SVC, n = 6), coronary sinus (CS, n = 10) or right pulmonary artery (R
118 y time for left ventricular lead deployment (coronary sinus [CS] cannulation to withdrawal of CS shea
119 in plasma levels between the aortic root and coronary sinus [CS]) in 9 patients undergoing right and
120 her a simpler pacing approach via the distal coronary sinus (CSd) could eliminate AF inducibility by
121 e (RA), left subclavian vein (LSV), proximal coronary sinus (CSos), and distal coronary sinus (DCS) i
122 RAap), distal coronary sinus (DCS), proximal coronary sinus (CSos), main/left pulmonary artery juncti
123 , proximal coronary sinus (CSos), and distal coronary sinus (DCS) in 14 patients with chronic atrial
124 in the right atrial appendage (RAap), distal coronary sinus (DCS), proximal coronary sinus (CSos), ma
127 ntly increased NO overflow measured from the coronary sinus during SS (93.25+/-59.20 versus 114.82+/-
129 coronary sinus leads, with the most proximal coronary sinus electrode pair straddling the coronary si
130 biventricular systems, with implantation of coronary sinus electrodes, will continue to challenge le
131 tion of far-field left atrium from the local coronary sinus electrograms besides appropriate adjustme
132 vasomotor responses to substance P (SP), and coronary sinus endothelin-1 and NO metabolite levels in
133 46+/-15% below baseline values (P=.007) at a coronary sinus estradiol concentration of 1725+/-705 pmo
135 of dietary control, catheters were placed in coronary sinus, femoral arterial and venous, and periphe
138 a resulted in 2.7- and 2.3-fold increases in coronary sinus flow at VEC MR imaging and flow probe CBF
140 VEC MR imaging has the potential to measure coronary sinus flow during different physiologic conditi
141 bal LV perfusion was quantified by measuring coronary sinus flow in an oblique imaging plane perpendi
144 ated in milliliters per minute per gram from coronary sinus flow, and LV mass was obtained by using V
145 cessory pathway; and 7) searching within the coronary sinus for a presumed accessory pathway potentia
148 ously from the left main coronary artery and coronary sinus for measurement of Lp-PLA2, lysophosphati
149 amples were withdrawn from the aorta and the coronary sinus for measurement of NO metabolites, O2 con
150 r to ablation of CFAEs in the left atrium or coronary sinus for up to 2 additional hours of procedure
152 us valves, and formation of the mouth of the coronary sinus from the cranial muscular wall of the lef
153 n that linked the superior vena cava and the coronary sinus from the CT model with a catheter placed
154 from the atrioventricular node artery to the coronary sinus, from the right coronary artery (RCA) to
155 CT can provide excellent information about coronary sinus function and coronary sinus-left atrium m
157 , or tended to have, lower concentrations of coronary sinus growth factors and plasma exerting a weak
161 atrial tachycardia, which was mapped to the coronary sinus in 3 patients, to the posterolateral righ
164 t changes in configuration were noted in the coronary sinus in any lead at packing sites < or = 32 mm
165 sinus catheterization; NOx concentrations in coronary sinus, in arterial and peripheral venous plasma
166 on alone, nitric oxide (NO) release into the coronary sinus increased from 219.8 to 544.9 pmol min-1
168 Left ventricular (LV) pacing through the coronary sinus is the standard approach for cardiac resy
169 was performed using a right atrial appendage/coronary sinus lead configuration in 38 patients with a
174 de atrial activation recorded in the lateral coronary sinus leads, and 12 had the earliest retrograde
175 atrial activation recorded in the posterior coronary sinus leads, with the most proximal coronary si
177 es in the atrial fibrillation group showed a coronary sinus-left atrium connection, which was single
181 vels rose rapidly with dramatic increases in coronary sinus levels indicative of myocardial release.
182 endothelial prostacyclin release, aortic and coronary sinus levels of ET-1 and 6-keto-prostaglandin F
185 l annular dimension with a PMA device in the coronary sinus may reduce functional mitral regurgitatio
186 a quadripolar catheter was performed in the coronary sinus (n = 29) and in the right atrium (n = 10)
188 c activity, whereas metoprolol did not lower coronary sinus norepinephrine and actually increased cen
190 ermined by the Fick method from arterial and coronary sinus O2 concentrations and from MBF obtained b
191 uloplasty can be achieved indirectly via the coronary sinus or directly from retrograde left ventricu
192 uloplasty can be achieved indirectly via the coronary sinus or directly from retrograde left ventricu
193 fficulties with efficient cannulation of the coronary sinus orifice in a rare anatomical variant.
194 crista terminalis, tricuspid valve isthmus, coronary sinus orifice, membranous fossa ovalis and pulm
203 aneously pacing at the high right atrium and coronary sinus ostium at an identical rate to the baseli
206 atrial pacing from the high right atrium and coronary sinus ostium can suppress inducible AF or atria
207 st retrograde activation was recorded at the coronary sinus ostium in 60% and 65% of patients with ty
209 with the IP maneuver, the incremental His-to-coronary sinus ostium maneuver was consistent with funct
210 period between the high right atrium and the coronary sinus ostium pacing sites was significantly gre
211 pathway in the right atrial septum near the coronary sinus ostium prevented the induction and clinic
212 t atrial pacing modes (high right atrium and coronary sinus ostium) and the long-term need for cardio
214 - 2.4 in length within 2.2 mm +/- 3.8 of the coronary sinus ostium, and proximal connections measured
222 ded for 131I-albumin, 42K and 201Tl from the coronary sinus outflow following injection into arterial
224 sponses (P < .05), associated with increased coronary sinus oxygen content, were observed for-ACh (+6
225 rtic pressure, coronary blood flow, arterial-coronary sinus oxygen difference (DeltaAVO(2)), and MVO(
229 need for epicardial ablation from within the coronary sinus (P<0.01) and the total length of the MIL
230 rded along the ablation line during proximal coronary sinus pacing at sites at which radiofrequency a
234 phrine, appearance rate of norepinephrine in coronary sinus plasma (cardiac norepinephrine spillover)
235 levels 100-fold (P<0.01), whereas aortic and coronary sinus plasma Ang I and II levels were unaffecte
237 and sodium nitroprusside (P<0.001), although coronary sinus plasma tPA antigen and activity concentra
238 of NO (nitrate+nitrite=NO(x)) in aortic and coronary sinus plasma using chemiluminescence to assess
239 dial interstitial fluid (ISF) and aortic and coronary sinus plasma were quantified by use of 3H-label
240 coronary blood flow, epicardial diameter and coronary sinus platelet cGMP content during intracoronar
241 pandable, stainless steel, hourglass-shaped, coronary-sinus reducing device creates a focal narrowing
242 is small clinical trial, implantation of the coronary-sinus reducing device was associated with signi
243 (two of whom died) and by perforation of the coronary sinus requiring pericardiocentesis in two other
245 ction during atrial systole, indicating that coronary sinus-right atrium muscle continuity is likely
247 coronary angiography with high accuracy, and coronary sinus sampling distinguished cardiac-derived fr
250 ances of the RA-left pulmonary artery and RA-coronary sinus shock vectors were similar (121 +/- 11 Om
251 ing was performed from electrodes within the coronary sinus showing activation later than adjacent el
252 a norepinephrine spillover measured from the coronary sinus significantly increased during SS and was
254 dal conduction during right and left atrial (coronary sinus) stimulation in 46 patients (27 women and
255 ncentrations were significantly lower in the coronary sinus than in the artery (P < 0.05; extraction
256 the nonpulmonary vein triggers includes the coronary sinus, the anterior part of the septum, the lef
257 ocal narrowing and increases pressure in the coronary sinus, thus redistributing blood into ischemic
259 regurgitation exploits the proximity of the coronary sinus to the mitral annulus, but is limited by
261 various regions of the left atrium, and the coronary sinus until AF terminated or all identified com
263 nd ablation catheters were inserted into the coronary sinus via femoral sheaths and into the right at
265 oventricular node artery passed close to the coronary sinus wall (mean distance, 2.1 mm +/- 0.7; rang
266 rug concentration in blood obtained from the coronary sinus was 3.0+/-0.4 (mean+/-SD) mg/L, similar i
270 Similarly, the superior vena cava and the coronary sinus were also reconstructed from these images
271 V1 and electrograms from the left atrium and coronary sinus were analyzed to determine the DF of AF b
273 nnulus and a decapole catheter placed in the coronary sinus were used for mapping during initiation t
275 n oblique imaging plane perpendicular to the coronary sinus with non-breath-hold VEC MR imaging.
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。